Reuters logo
BRIEF-Teleflex commences phase I clinical study of RePlas freeze-dried plasma
May 15, 2017 / 10:39 AM / in 5 months

BRIEF-Teleflex commences phase I clinical study of RePlas freeze-dried plasma

May 15 (Reuters) - Teleflex Inc

* Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma

* Teleflex inc- RePlas, a lyophilized fresh frozen plasma product, being developed in collaboration with U.S. Army medical materiel development activity Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below